Spain

Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, European Union, Extent of Protection, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Netherlands, Norway, Pharma, Poland, Portugal, Romania, Scope of protection, Slovakia, Slovenia, Spain, SPC, Sweden, United Kingdom, Validity

(Bristows)/ /2 Comments

Yesterday, 25 April 2018, AG Wathelet has handed down his opinion in the Teva v Gilead reference (Case C-121/17) suggesting that the question should be answered as follows: “The fact that a substance or combination of substances falls within the scope of protection of the basic patent is a necessary, but not sufficient, requirement for…

EPO, Inventive step, Prior art, Spain

(Clifford Chance)/ /7 Comments

In one of the saga of cases that involved Societé des Produits Nestlé and companies that are trying to market capsules compatible with Nescafé’s Dolce Gusto system, the defendant alleged, among other arguments, that some of the patents asserted were null due to a lack of inventive step. The case was handled by Commercial Court…

Case Law, Spain

(Clifford Chance)/ /1 Comment

A Spanish patents court rules for the first time on the sometimes blurry line dividing “discoveries” and “inventions”. The Court found that a method for prenatal diagnosis based on the discovery that sufficient fetal DNA can also be detected in maternal serum or plasma is a non-patentable discovery, because it lacks any “additional technical teaching”…

Case Law, Spain

(Clifford Chance)/

In a long-awaited judgment, the Spanish Supreme Court has clarified the application of the TRIPS agreement to patent applications affected by the Spanish reservation to the EPC: Article 70.7 of TRIPS allowed owners of patent applications filed before 7 October 1992, but which were still pending when TRIPS came into force, to amend the patents…

Case Law, Spain, SPC

(Clifford Chance)/

In our last blog (Will the Spanish Patent Office accept the modification of an SPC’s term after the Incyte judgment?), published on 8 January 2018, we raised the question as to whether the Spanish Patent and Trademark Office (“SPTO”) would accept the modification of the term of a supplementary protection certificate (“SPC”) after the judgment…

CJEU, Spain, SPC

(Clifford Chance)/

Readers will recall that, in its judgment of 6 October 2015 (Case C-471/14, Seattle Genetics), the CJEU concluded that the relevant date for calculating the term of a supplementary protection certificate (“SPC”) is not the date on which a marketing authorisation (“MA”) is granted, but the date when the addressee is notified of the decision…